Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Protagenic Therapeutics, Inc.\newPTIX | Open-market buy | 23/10/12 | 23/10/13 | 8,000 sh | $0.81 | $6,480 | +21.2% |
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Protagenic Therapeutics, Inc.\newPTIX | Open-market buy | 23/10/12 | 23/10/13 | 8,000 sh | $0.81 | $6,480 | +21.2% |